Abstract
The oral cavity forms the most proximal portion of the alimentary tract and serves as part of the upper airway. It provides the portal of entry to the body for food and fluids and serves as the initial site of digestive function through the mechanisms of mastication and salivation. The structures within the mouth, including the palate, tongue, and buccal regions, are an integral part of the speech apparatus. The oral mucosa is a protective barrier and collects sensory information relating to touch, pain, temperature, and taste. Efforts to treat tumors arising in the oral cavity must be directed not only at preserving the life of the patient, but also at preserving these functions as completely as possible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Lederman M. Cancer of the oral cavity: Observations on classification and natural history. Int J Radiat Oncol Biol Phys (6): 1559–1565, 1980.
Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, and larynx. J Surg Oncol (6): 357–380, 1974.
Frazell EL. A review of the treatment of cancer of the mobile portion of the tongue. Cancer (28): 1178–1181, 1971.
Fletcher GH. Place of irradiation in the management of head and neck cancers. Semin Oncol (4): 375–385, 1977.
Fitzpatrick PJ, Tepperman BS. Carcinoma of the floor of the mouth. J. Can Assoc Radiol (33): 148–153, 1982.
Hintz B, Charyulu K, Chandler JR, Sudarsanam A, Garciga C. Randomized study of local control and survival following radical surgery or radiation therapy in oral and laryngeal carcinomas. J Surg Oncol (12): 61–74, 1979.
Ange DW, Lindberg RD, Guillamondegui OM. Management of squamous cell carcinoma of the oral tongue and floor of mouth after excisional biopsy. Radiology (116): 143–146, 1975.
Fu KK, Chan EK, Phillips TL, Ray JW. Time, dose and volume factors in interstitial radium implants of carcinoma of the oral tongue. Radiology (119): 209–213, 1976.
Chu A, Fletcher GH. Incidence and causes of failures to control by irradiation the primary lesions in squamous cell carcinomas of the anterior two-thirds of the tongue and floor of mouth. AJR (117): 502–508, 1973.
Lees AW. The treatment of carcinoma of the anterior two-thirds of the tongue by radiotherapy. Int J Radiat Oncol Biol Phys (1): 849–858, 1976.
Mendenhall WM, Million RR, Cassisi NJ. Elective neck irradiation in squamous-cell carcinoma of the head and neck. Head Neck Surg (3): 15–20, 1980.
Gilbert EH, Goffinet DR, Bagshaw MA. Carcinoma of the oral tongue and floor of mouth: Fifteen years’ experience with linear accelerator therapy. Cancer (35): 1517–1524, 1975.
Pierquin B, Chassagne D, Baillet F, Castro JR. The place of implantation in tongue and floor of mouth cancer. JAMA (215): 961–963, 1971.
Bedwinek JM, Shukovsky LJ, Fletcher GH, Daley TE. Osteonecrosis in patients treated with definitive radiotherapy for squamous cell carcinomas of the oral cavity and naso- and oropharynx. Radiology (119): 665–667, 1976.
Fayos JV. The role of radium implants in cancer of the oral cavity and oral pharynx. Int J Radiat Oncol Biol Phys (6): 423–429, 1980.
Fletcher GH. Textbook of Radiotherapy, 3rd ed. Philadelphia: Lea and Febiger, 1980.
Sahatchiev A, Moushmov M, Kirov S. Results of radical treatment of cancer of the anterior two-thirds of the tongue. Cancer (30): 703–707, 1972.
Richaud P, Tapley ND: Lateralized lesions of the oral cavity and oropharynx treated in part with the electron beam. Int J Radiat Oncol Biol Phys (5): 461–465, 1979.
Barker JL, Fletcher GH. Time, dose and tumor volume relationships in megavoltage irradiation of squamous cell carcinomas of the retromolar trigone and anterior tonsillar pillar. Int J Radiat Oncol Biol Phys (2): 407–414, 1977.
Chung CK, Rahman SM, Lim ML, Constable WC. Squamous cell carcinoma of the hard palate. Int J Radiat Oncol Biol Phys (5): 191–196, 1979.
Farr HW, Arthur K. Epidermoid carcinoma of the mouth and pharynx, 1960–1964. Elective radical neck dissection. Clin Bull (1): 130–135, 1971.
Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev (2): 177–191, 1975.
Ketcham AS, Hoye RC, Chretien PB, Brace KC. Irradiation twenty-four hours preopera-tively. Am J Surg (118): 691–697, 1969.
Lawrence WJr, Terz JJ, Rogers C, King RE, Wolf JS, King ER. Preoperative irradiation for head and neck cancer: A prospective study. Cancer (33): 318–323, 1974.
Kramer S. Comparison of preoperative and postoperative radiation therapy for patients with carcinoma of the head and neck—The RTOG Study. Presented at Am Soc Ther Radiol, 1980.
Hamberger AD, Fletcher GH, Guillamondegui OM, Byers RM. Advanced squamous cell carcinoma of the oral cavity and oropharynx treated with irradiation and surgery. Radiology (119): 433–438, 1976.
Marcus RB, Million RR, Cassisi NJ. Postoperative irradiation for squamous cell carcinomas of the head and neck: Analysis of time-dose factors related to control above the clavicles. Int J Radiat Oncol Biol Phys (5): 1943–1949, 1979.
Vikram B. Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head and neck cancer. Int J Radiat Oncol Biol Phys (5): 1837–1840, 1979.
Looser KG, Shah JP, Strong EW. The significance of “positive” margins in surgically resected epidermoid carcinomas. Head Neck Surg (1): 107–111, 1978.
Fletcher GH, Evers WT. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology (95): 185–188, 1970.
Kraus FT, Perez-Mesa C. Verrucous carcinoma. Cancer (19): 26–38, 1966.
Memula N, Ridenhour G, Doss LL. Radiotherapeutic management of oral cavity verrucous carcinoma. Proc. 22nd Annual Meeting Amer Soc Ther Radiol, Int J Radiat Oncol Biol Phys (6): 1404, 1980.
Burns HP, Van Nostrand AWP, Palmer JA. Verrucous carcinoma of the oral cavity: Management by radiotherapy and surgery. Can J Surg (23): 19–25, 1980.
Fayos JV. Carcinoma of the mandible. Result of radiation therapy. Acta Radiol (Ther) (12): 378–386, 1973.
Porter EH. The local prognosis after radical radiotherapy for squamous carcinoma of the alveolus or the floor of the mouth. Clin Radiol (22): 139–143, 1971.
Henk JM. Radiosensitivity of lymph node metastases. Proc R Soc Med (68): 85–86, 1975.
del Regato JA, Spjut HJ. Ackerman and del Regato’s Cancer Diagnosis, Treatment, and Prognosis, 5th Ed. St. Louis: C.V. Mosby, 1977.
Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer (29): 1446–1449, 1972.
Mendenhall WM, Million RR, Cassisi NJ. Elective neck irradiation in squamous cell carcinoma of the head and neck. Head Neck Surg (3): 15–20, 1980.
Beahrs OH, Barber KW Jr. The value of radical dissection of structures of the neck in the management of carcinoma of the lip, mouth, and larynx. Arch Surg (85): 49–56, 1962.
Lyall D, Shetlin CF. Cancer of the tongue. Ann Surg (135): 489–496, 1952.
Sako K, Pradier RN, Marchetta FC, Pickren JW. Fallibility of palpation in the diagnosis of metastases to cervical nodes. Surg Gynecol Obstet (118): 989–990, 1964,
Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity. Cancer (46): 386–390, 1980.
Pointon, RC. Personal communication.
Jesse RH, Barkley HT Jr, Lindberg RD, Fletcher GH. Cancer of the oral cavity. Is elective neck dissection beneficial? Am J Surg (120): 505–508, 1970.
Northrop M, Fletcher GH, Jesse RH, Lindberg RD. Evolution of neck disease in patients with primary squamous cell carcinoma of the oral tongue, floor of mouth, and palatine arch, and clinically positive neck nodes neither fixed nor bilateral. Cancer (29): 23–30, 1972.
Nahum AM, Bone RC, Davidson TM. The case for elective prophylactic neck dissection. Trans Am Acad Ophtholmol Otolaryngol (82): 603–612, 1976.
Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer (29): 1450–1454, 1972.
Bagshaw MA, Thompson RW. Elective irradiation of the neck in patients with primary carcinoma of the head and neck. JAMA (217): 456–458, 1971.
Million RR. Elective neck irradiation for TxNo squamous carcinoma of the oral tongue and floor of mouth. Cancer (34): 149–155, 1974.
Horiuchi J, Adachi T. Some considerations on radiation therapy of tongue cancer. Cancer (28): 335–339, 1971.
Goffinet DR, Gilbert EH, Weller SA, Bagshaw MA. Irradiation of clinically uninvolved cervical lymph nodes. Can J Otolaryngol (4): 927–933, 1975.
Toker C. Some observations on the distribution of metastatic squamous carcinoma within cervical lymph nodes. Ann Surg (157): 419–426, 1963.
Wizenberg MJ, Bloedorn FG, Weiner S, Gracia J. Treatment of lymph node metastases in head and neck cancer. A radiotherapeutic approach. Cancer (29): 1455–1462, 1972.
Hanks GE, Bagshaw MA, Kaplan HS. The management of cervical lymph node metastasis by megavoltage radiotherapy. AJR (105): 74–82, 1969.
Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer (40): 145–151, 1977.
Strong EW. Preoperative radiation and radical neck dissection. Surg Clin North Am (49): 271–276, 1969.
Schneider JJ, Fletcher GH, Barkley HT Jr. Control by irradiation alone of nonfixed clinically positive lymph nodes from squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. AJR (123): 42–48, 1975.
Bataini JP, Brugere J, Ghossein NA, Bernier J, Jaulerry C, Brunin F. Radiotherapeutic control of subclinical and clinical neck disease in patients with cancers of supraglottic larynx and pharynx. Proc. International Head and Neck Oncology Research Conference, Rosslyn, Virginia, Sept. 8–10, 1980. Abstract 1.2.
Cachin Y, Sancho-Garnier H, Micheau C, Marandas P. Nodal metastasis from carcinomas of the oropharynx. Otolaryngol Clin North Am (12): 145–154, 1979.
Goodwin WJ Jr, Chandler JR. Indications for radical neck dissection following radiation therapy. Arch Otolaryngol (104): 367–370, 1978.
Barkley HT Jr, Fletcher GH, Jesse RH, Lindberg RD. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg (124): 462–467, 1972.
Garofalo JA, Erlandson E, Strong EW, Lesser M, Gerold F, Spiro R, Schwartz M, Good RA. Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck. J Surg Oncol (15): 381–386, 1980.
Silverman NA, Alexander JC Jr, Chretien PB. CEA levels in head and neck cancer. Cancer (37): 2204–2211, 1976.
Osoba D, Kersey PA, Clark RM, Rosen IB. Prognostic value of skin testing with dinitro-chlorobenzene in patients with head and neck cancer. Can J Surg (23): 43–44, 1980.
Molinari R. Study for a possible monitoring of radiosensitivity of oral and oropharyngeal carcinoma using evaluation of potential proliferative activity (L.I.). Proc. International Head and Neck Oncology Research Conference, Rosslyn, Virginia, Sept. 1980. Abstract 4.4.
Suit H, Lindberg R, Fletcher GH. Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology (84): 1100–1107, 1965.
Fazekas JT, Green JP, Vaeth JM, Schroeder AF. Postirradiation induration as a prognosticator. A retrospective analysis of squamous-cell carcinomas of the oral cavity and oropharynx. Radiology (102): 409–412, 1972.
Barkley HT Jr, Fletcher GH. The significance of residual disease after external irradiation of squamous-cell carcinoma of the oropharynx. Radiology (124): 493–495, 1977.
Mantyla M, Kortekangas AE, Valavaara RA, Nordman EM. Tumor regression during radiation treatment as a guide to prognosis. Br J Radiol (52): 972–977, 1979.
Sobel S, Rubin P, Keller B, Poulter C. Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys (1): 873–880, 1976.
Taylor SG. Head and neck cancer. In Cancer Chemotherapy 1979, Annual 3, Pinedo HM (ed). New York: Elsevier, 1981, pp. 263–278.
Fazekas JT, Sommer C, Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys (6): 533–541, 1980.
Fu KK, Silverberg IJ, Phillips TL, Friedman MA. Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: Results of a Radiation Therapy Oncology Group Pilot Study. Cancer Treat Rep (63): 351–357, 1979.
Lo TCM, Wiley AL Jr, Ansfield FJ, Brandenburg JH, Davis HL Jr, Gollin FF, Johnson RO, Ramirez G, Vermund H. Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. AJR (126): 229–235, 1976.
Elkind MM. Fundamental questions in the combined use of radiation and chemicals in the treatment of cancer. Int J Radiat Oncol Biol Phys (5): 1711–1720, 1979.
Combined Modalities. Chemotherapy/radiotherapy—Meeting summary. Int J Radiat Oncol Biol Phys (5): 1721–1723, 1979.
Goldsmith MA, Carter SK. The integration of chemotherapy into a combined modality approach to cancer therapy. V. Squamous cell cancer of the head and neck. Cancer Treat Rev (2): 137–158, 1975.
Fu KK. Normal tissue effects of combined radiotherapy and chemotherapy for head and neck cancer. Front Radiat Ther Oncol (13): 113–132, 1979.
Chassagne D, Richard JM, Le Floch O. Results of interstitial curietherapy in T3 and T4 floor of the mouth and tongue cancers after previous arterial infusion chemotherapy. Panminerva Med (18): 45–49, 1976.
Cachin Y, Jortay A, Sancho H, Eschwege F, Madelain M, Desaulty A, Gerard P. Preliminary results of a randomized EORTC study comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx. Eur J Cancer (13): 1389–1395, 1977.
Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiol (31): 617–620, 1980.
O’Connor AD, Clifford P, Dalley VM, Durden-Smith DJ, Edwards WG, Hollis BA. Advanced head and neck cancer treated by combined radiotherapy and VBM cytotoxic regimen—four-year results. Clin Otolaryngol (4): 329–337, 1979.
Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol (26): 638–648, 1953.
Rubin P, Hanley J, Keys HM, Marcial V, Brady L. Carbogen breathing during radiation therapy. Int J Radiat Oncol Biol Phys (5): 1963–1970, 1979.
Henk JM, Kunkler PB, Smith CW. Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial. Lancet (II): 101–103, 1977.
Medical Research Council Working Party. Radiotherapy and hyperbaric oxygen. Lancet (II): 881–884, 1978.
Dische S. Hyperbaric oxygen: The Medical Research Council trials and their clinical significance. Br J Radiol (51): 888–894, 1979.
Raju MR. Heavy Particle Radiotherapy. London: Academic Press, 1980.
Catterall M, Bewley DK. Fast Neutrons in The Treatment of Cancer. New York: Academic Press, 1979.
Griffin TW, Weisberger EC, Laramore GE, Tong D, Blasko JC. Complications of combined surgery and neutron radiation therapy in patients with advanced carcinoma of the head and neck. Radiology (132): 177–178, 1979.
L.W. Brady (ed). Radiation Sensitizers, Their Use in The Clinical Management of Cancer. Masson Publishing U.S.A., 1980.
Denekamp J, McNally NJ, Fowler JF, Joiner MC. Misonidazole in radiotherapy: Are many small fractions best? Br J Radiol (53): 981–990, 1980.
Fazekas JT, Goodman RL, McLean CJ. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer. An RTOG pilot study (78–02). Int J Radiat Oncol Biol Phys (7): 1703–1708, 1981.
Sealy R, Williams A, Levin W, Blair R, Flockhart I, Stratford M, Minchinton A, Cridland S. Progress in investigations in the use of misonidazole in head and neck cancer as a hypoxic cell Radiation sensitizer and in combination with hyperbaric oxygen or hyperthermia. In Radiation Sensitizers: Their Use in the Clinical Management of Cancer, Brady LW (ed). Masson Publishing U.S.A., 1980, pp. 361–365.
Bush RS, Jenkin RDT, Allt WEC, Beale FA, Bean H, Dembo AJ, Pringle JF. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer (37) (Suppl III): 302–306, 1978.
Siemann DW, Hill RP, Bush RS. Smoking: The influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to Radiation. Int J Radiat Oncol Biol Phys (4): 657–662, 1978.
Pierquin BM, Mueller WK, Baillet F. Low dose rate ir Radiation of advanced head and neck cancers: Present status. Int J Radiat Oncol Biol Phys (4): 565–572, 1978.
Shukovsky LJ, Fletcher GH, Montague ED, Withers HR. Experience with twice-a-day fractionation in clinical radiotherapy. AJR (126): 155–162, 1976.
Backström A, Jakobsson PA, Littbrand B, Wersall J. Fractionation scheme with low individual doses in irradiation of carcinoma of the mouth. Acta Radiol (Ther) (12): 401–406, 1973.
Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences. Int J Radiat Oncol Biol Phys (7): 99–104, 1981.
Au SC, Archambeau JO. Continuous external irradiation. Int J Radiat Oncol Biol Phys (5): 253–255, 1979.
Holsti LR. Clinical experience with split-course radiotherapy. A randomized clinical trial. Radiology (92): 591–596, 1969.
Abramson N, Scruggs RP, Cavanaugh PJ. Short-course radiation therapy in the treatment of head and neck tumors. Radiology (118): 175–178, 1976.
Pilepich MV, Munzenrider JE, Rene JB. Unorthodox fractionation in the treatment of head and neck tumors. Int J Radiat Oncol Biol Phys (5): 249–252, 1979.
Million RR, Zimmermann RC. Evaluation of University of Florida split-course technique for various head and neck squamous cell carcinomas. Cancer (35): 1533–1536, 1975.
Wang CC. Radiation therapy in the management of oral malignant disease. Otolaryngol Clin North Am (12): 73–80, 1979.
Harwood AR, Cummings BJ. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys (8): 1121–1126, 1982.
Rubin P, Casarett GW. Clinical Radiation Pathology. Philadelphia: W.B. Saunders, 1968.
Beumer J III, Curtis T, Harrison RE. Radiation therapy of the oral cavity: Sequelae and management, Part 1. Head Neck Surg (1): 301–312, 1979.
Beumer J, Curtis T, Harrison RE. Radiation therapy of the oral cavity: Sequelae and management, Part 2. Head Neck Surg (1): 392–408, 1979.
Phillips TL. Rationale for initial clinical trials and future development of radioprotectors. Cancer Clin Trials (3): 165–173, 1980.
Starcke EN, Shannon IL. How critical is the interval between extractions and irradiation in patients with head and neck malignancy? Oral Surg (43): 333–337, 1977.
Daley TE, Drane JB. Management of Dental Problems in Irradiated Patients. Houston: University of Texas Press, 1972.
Carl W, Schaaf NG. Dental care for the cancer patient. J Surg Oncol (6): 293–310, 1974.
Murray CG, Herson J, Daly TE, Zimmerman S. Radiation necrosis of the mandible: A 10-year study. Part I. Factors influencing the onset of necrosis. Int J Radiat Oncol Biol Phys (6): 543–548, 1980.
Murray CG, Herson J, Daly TE, Zimmerman S. Radiation necrosis of the mandible: A 10-year study. Part II. Dental factors; onset, duration and management of necrosis. Int J Radiat Oncol Biol Phys (6): 549–553, 1980.
Murray CG, Daly TE, Zimmerman SO. The relationship between dental disease and radiation necrosis of the mandible. Oral Surg (49): 99–104, 1980.
Davis JC, Dunn JM, Gates GA, Heimbach RD. Hyperbaric oxygen: A new adjunct in the management of radiation necrosis. Arch Otolaryngol (105): 58–61, 1979.
Joseph DL, Shumrick DL. Risks of head and neck surgery in previously irradiated patients. Arch Otolaryngol (97): 381–384, 1973.
Donaldson SS. Nutritional consequences of radiotherapy. Cancer Res (37): 2407–2413, 1977.
Sobol SM, Conoyer JM, Zill R, Thawley SE, Ogura JH. Nutritional concepts in the management of the head and neck cancer patient. II. Management concepts. Laryngoscope (89): 962–979, 1979.
Wynder EL, Dodo H, Bloch DA, Gantt RC, Moore OS. Epidemiologic investigation of multiple primary cancer of the upper alimentary and respiratory tracts. I. A retrospective study. Cancer (24): 730–739, 1969.
Kogelnik HD, Fletcher GH, Jesse RH. Clinical course of patients with squamous cell carcinoma of the upper respiratory and digestive tracts with no evidence of disease 5 years after initial treatment. Radiology (115): 423–427, 1975.
Cummings BJ, Clark RM. Cancer of the oral cavity. J Otolaryngol (11): 359–364, 1982.
Decroix Y, Ghossein NA. Experience of the Curie Institute in treatment of cancer of the mobile tongue. II Management of the neck nodes. Cancer (47): 503–508, 1981.
Glick JH, Taylor SG. Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: A review. Int J Radiat Oncol Biol Phys (7): 229–242, 1981.
Duncan W, Arnott SJ, Orr JA, Kerr GR. The Edinburgh experience of fast neutron therapy. Int J Radiat Oncol Biol Phys (8): 2155–2157, 1982.
Griffin TW, Lawrence GE, Hussey DH, Hendrickson FR, Rodriguez-Antunez A. Fast neutron beam radiation therapy in the United States. Int J Radiat Oncol Biol Phys (8): 2165–2168, 1982.
Phillips TL, Wasserman TH, Stetz J, Brady LW. Clinical trials of hypoxic cell sensitizers. Int J Radiat Oncol Biol Phys (8): 327–334, 1982.
Cummings BJ, Thomas GM, Rauth AM, Sorrenti V, Black B, Bush RS. Neurotoxic radiosensitizers and head and neck cancer patients — how many will benefit? Int J Radiat Oncol Biol Phys (8): 343–345, 1982.
Kotalik JF. Multiple daily fractions in radiotherapy. Cancer Treat Rev (8): 127–146, 1981.
Withers HR, Peters LJ, Thames HD, Fletcher GH. Hyperfractionation. Int J Radiat Oncol Biol Phys (8): 1807–1809, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Cummings, B.J. (1984). Radiotherapy Aspects of Malignant Diseases of the Oral Cavity. In: van der Waal, I., Snow, G.B. (eds) Oral Oncology. Developments in Oncology, vol 20. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2845-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2845-2_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9796-3
Online ISBN: 978-1-4613-2845-2
eBook Packages: Springer Book Archive